The treatment of refractory terminal heart failure has been heart transplantation. However, there are limitations with regard to clinical conditions of the recipient and availability of donors, and ventricular support has therefore been alternatively used as destination therapy. We describe the case is of a female patient with ischemic cardiomyopathy-associated heart failure who had a left ventricular assist device successfully implanted and at eight months of the procedure was at functional class I, with no complications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.24875/GMM.18004321 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!